MARINER Trial: Multiparametric Cardiac PET for CAV Surveillance After Heart Transplantation

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
Cardiac allograft vasculopathy (CAV) is a common complication affecting heart transplant patients. This condition causes narrowing of the heart arteries leading to graft dysfunction. Surveillance for CAV is vital; however an ideal approach has not been established. The goal of this study is to assess whether noninvasive positron emission tomography (PET) based surveillance is non-inferior to invasive coronary angiography (ICA) surveillance.
Epistemonikos ID: 4cb6ab4ba4fb6dba6f660def634e21eb99adcfd2
First added on: May 15, 2024